This trial is active, not recruiting.

Conditions smoking, tobacco use disorder
Treatments quitadvisormd software algorithm, standard smoking cessation counseling
Phase phase 2
Sponsor Silverchair Science & Communications, LLC
Collaborator National Institute on Drug Abuse (NIDA)
Start date January 2011
End date April 2015
Trial size 100 participants
Trial identifier NCT01065493, R44 DA026682, R44DA026682


QuitAdvisorMD: A point-of-care tool for brief smoking cessation interventions Under a Phase II SBIR grant supported by NIH/NIDA, we are developing QUITAdvisorMD: a point-of-care, patient-centered resource for counseling patients who smoke or use tobacco products. It is based on the principles of Motivational Interviewing, a non-confrontational and very effective method for intervening and treating these patients; the 5 A's of behavioral interventions; and the Transtheoretical Model of Change. Through a point and click interface, the tool uses a series of interview questions designed to motivate patients to stop smoking by first assessing their stage of change and then offering effective stage-based interventions and interview techniques. The tool also offers stage-tailored patient information, a clinician educational reference, and the ability to communicate support information patients via email and/or text message.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose prevention
quitadvisormd software algorithm
QuitAdvisorMD, a set of brief clinical assessments, counseling scripts and intervention instruments for smoking cessation in primary care settings
(Active Comparator)
Status quo smoking cessation counseling.
standard smoking cessation counseling
Standard Smoking Cessation Counseling

Primary Outcomes

The goal of the evaluation is to assess the ability of QuitAdvisorMD to influence smoking cessation as measured by the primary outcome of the increase in physician initiated smoking cessation counseling.
time frame: 12 Months

Secondary Outcomes

Secondary outcomes will include, 1) the increase in ability of clinicians to provide appropriate stage-based smoking cessation assistance, and 2) the increase in patient quit attempts.
time frame: 12 Months

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - any physician providing care for members of Southern Health through primary care and have access to a point-of-care computing device (Smartphone, desktop PC, etc) during patient visits. Exclusion Criteria: - Lack of appropriate computing device

Additional Information

Official title QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions
Principal investigator George Reynolds, BA
Trial information was received from ClinicalTrials.gov and was last updated in November 2014.
Information provided to ClinicalTrials.gov by Silverchair Science & Communications, LLC.